Strategies for Precise Engineering and Conjugation of Antibody Targeted-nanoparticles for Cancer Therapy

Abstract

Improvements in the diagnosis and treatment of cancer are urgently needed for use in nanotechnology. Nanoparticles (NPs) can reduce the side effects of traditional chemotherapy by sustained release of loaded drugs and increase therapeutic efficiency. NPs can also enhance endothelial permeation retention by size effect and its accumulation in tumor cells through passive targeting. Furthermore, it is critical to treat cancer with a controlled targeted drug which can be specifically delivered into tumor cells and released there, resulting in a targeted therapy to eradicate tumor cells while sparing normal cells. To this end, antibody-mediated targeting therapy has been developed, but imperfections in antibodies (Abs) limit this therapy. Therefore, the combination of NPs and Abs has been highly valued in recent years, because conjugating special Abs on the surface of NPs can increase targeting efficiency, enabling selective delivery of anti-cancer drugs to tumor cells. In this mini-review, we would like to enumerate the strategies for the conjugation of Abs to the surface of the NPs as well as the precise engineering of targeted NPs. The application of targeting antibody fragments in this drug delivery system will also be discussed.

Keywords

cancer / drug delivery / nanoparticle / antibody / conjugation

References

[1] MattiuzziC, LippiG. Current Cancer Epidemiology. J Epidemiol Glob Health, 2019, 9(4): 217-222

[2] MyungJH, TamKA, ParkSJ, et al.. Recent advances in nanotechnology-based detection and separation of circulating tumor cells. Wiley Interdiscip Rev: Nanomed. Nanobiotechnol, 2016, 8(2): 223-239

[3] MukherjeeS, PrasadE, ChadhaA. H-Bonding controls the emission properties of functionalized carbon nano-dots. Phys Chem Chem Phys, 2017, 19(10): 7288-7296

[4] AgarwalRA, GuptaNK. Integration of Ag/AgCl and Au nanoparticles into isostructural porous coordination polymers of Ni (II), Co (II) and Mn (II): magnetic studies. Rsc Advances, 2017, 7(7): 3870-3878

[5] LinZ, DingJ, SunG, et al.. Application of Paclitaxel-loaded EGFR Peptide-conjugated Magnetic Polymeric Liposomes for Liver Cancer Therapy. Curr Med Sci, 2020, 40(1): 145-154

[6] BazakR, HouriM, El AchyS, et al.. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol, 2015, 141(5): 769-784

[7] HeidariAJ. Clinical trials of dendritic cell therapies for cancer exposing vulnerabilities in human cancer cells’ metabolism and metabolomics: new discoveries, unique features inform new therapeutic opportunities, biotech’s bumpy road to the market and elucidating the biochemical programs that support cancer initiation and progression. Int J Biol Med Sci, 2017, 1(1): e103

[8] SenterPJ. Potent antibody-based conjugates for cancer therapy: From early stage research to a clinically approved drug. Planta Med, 2015, 81(11): SL10

[9] RichardsDA, MaruanA I, ChudasamaVJ. Antibody fragments as nanoparticle targeting ligands: a step in the right direction. Chem Sci, 2017, 8(1): 63-77

[10] LiuYT, LiK, LiuB, et al.. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials, 2010, 31(35): 9145-9155

[11] ZhaoJ, MiY, LiuY, et al.. Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend. Biomaterials, 2012, 33(6): 1948-1958

[12] GuF, ZhangL, TeplyBA, et al.. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci, 2008, 105(7): 2586-2591

[13] YuK, ZhouY, LiY, et al.. Comparison of three different conjugation strategies in the construction of herceptin-bearing paclitaxel-loaded nanoparticles. Biomater Sci, 2016, 4(8): 1219-1232

[14] CaoJ, ChoiJS, OshiMA, et al.. Development of PLGA micro- and nanorods with high capacity of surface ligand conjugation for enhanced targeted delivery. Asian J Pharm Sci, 2019, 14(1): 86-94

[15] AlibolandiM, RamezaniM, SadeghiF, et al.. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. Int J Pharm, 2015, 479(1): 241-251

[16] YallapuMM, MaherDM, SundramV, et al.. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res, 2010, 3(1): 11

[17] DengZW, ZhenZP, HuXX, et al.. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials, 2011, 32(21): 4976-4986

[18] ChattopadhyayN, CaiZL, PignolJP, et al.. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer. Mol Pharm, 2010, 7(6): 2194-2206

[19] CarpinLB, BickfordLR, AgollahG, et al.. Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cell. Breast Cancer Res Treat, 2011, 125(1): 27-34

[20] Jovčevska I, Muyldermans S. The Therapeutic Potential of Nanobodies. BioDrugs, 2019:1–16

[21] SunW, HuX, LiuJ, et al.. A novel multi-walled carbon nanotube-based antibody conjugate for quantitative and semi-quantitative lateral flow assays. Biosci Biotechnol Biochem, 2017, 81(10): 1874-1882

[22] BhardwajJ, DevarakondaS, KumarS, et al.. Development of a paper-based electrochemical immunosensor using an antibody-single walled carbon nanotubes bioconjugate modified electrode for label-free detection of foodborne pathogens. Sens Actuators, 2017, 253(12): 115-123

[23] HadjipanayisCG, MachaidzeR, KaluzovaM, et al.. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced telivery and targeted therapy of glioblastoma. Cancer Res, 2010, 70(15): 6303-6312

[24] ZouP, YuYK, WangYA, et al.. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. Mol Pharm, 2010, 7(6): 1974-1984

[25] YallapuMM, FoySP, JainTK, et al.. PEG-Functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications. Pharm Res, 2010, 27(11): 2283-2295

[26] JiangW, FangH, LiuF, et al.. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging. Int J Nanomed, 2019, 14: 5611-5622

[27] ZhangL, FangY, KopečekJ, et al.. A new construct of antibody-drug conjugates for treatment of B-cell non-Hodgkin’s lymphomas. Eur J Pharm Sci, 2017, 103: 36-46

[28] Martínez-JotharL, DoulkeridouS, SchiffelersRM, et al.. Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting. J Controlled Release, 2018, 282: 101-109

[29] ThondawadaM, WadhwaniAD, PalanisamyDS, et al.. An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. Drug Dev Ind Pharm, 2018, 44(7): 1120-1129

[30] WangJ, TianSM, PetrosR A, et al.. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J Am Chem Soc, 2010, 132(32): 11306-11313

[31] BaeKH, LeeK, KimC, et al.. Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials, 2011, 32(1): 176-184

[32] VenturelliE, FabbroC, ChaloinO, et al.. Antibody covalent immobilization on carbon nanotubes and assessment of antigen binding. Small, 2011, 7(15): 2179-2187

[33] Rastgoo-LahroodA, MartsinovichN, LischkaM, et al.. From Au-Thiolate Chains to Thioether Sierpiński Triangles: The Versatile Surface Chemistry of 1, 3, 5-Tris (4-mercaptophenyl) benzene on Au (111). Acs Nano, 2016, 10(12): 10901-10911

[34] KaoHW, LinYY, ChenCC, et al.. Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model. Nanotechnology, 2014, 25(29): 295102

[35] CuradoN, Dewaele-Le RoiG, PotyS, et al.. Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines. Chem Commun, 2019, 55(10): 1394-1397

[36] GregoritzaM, MessmannV, AbstiensK, et al.. Controlled antibody release from degradable thermoresponsive hydrogels cross-linked by Diels-Alder chemistry. Biomacromolecules, 2017, 18(8): 2410-2418

[37] MazzucchelliS, ColomboM, De PalmaC, et al.. Single-Domain Protein A-engineered magnetic nanoparticles: Toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells. Acs Nano, 2010, 4(10): 5693-5702

[38] MelanconMP, LuW, ZhongM, et al.. Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer. Biomaterials, 2011, 32(30): 7600-7608

[39] KhanJA, KudgusRA, SzabolcsA, et al.. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. Plos One, 2011, 6(6): e20347

[40] ZhangXQ, LamR, XuXY, et al.. Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy. Adv Mater, 2011, 23(41): 4770-4774

[41] CreixellM, HerreraA P, AyalaV, et al.. Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells. J Magn Magn Mater, 2010, 322(15): 2244-2250

[42] SandovalMA, SloatBR, LansakaraPDSP. EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity. J Controlled Release, 2012, 157(2): 287-296

[43] YousefpourP, AtyabiF, Vasheghani-FarahaniE, et al.. Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab. Int J Nanomed, 2011, 6: 1977-1990

[44] WayT D, ChangCJ, LinCW. Bioconjugated fluorescent polymeric nanoparticles for imaging and targeted therapy of HER2-overexpressing cancer cells. J Fluoresc, 2011, 21(4): 1669-1676

[45] DilnawazF, SinghA, MohantyC, et al.. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials, 2010, 31(13): 3694-3706

[46] LeiTJ, SrinivasanS, TangY, et al.. Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms. Nanomed Nanotechnol Biol Med, 2011, 7(3): 324-332

[47] UngureanuC, KroesR, PetersenW, et al.. Light interactions with gold nanorods and cells: Implications for photothermal nanotherapeutics. Nano Lett, 2011, 11(5): 1887-1894

[48] ZhaoM, MengL, MaL, et al.. Layer-by-layer grafting CNTs onto carbon fibers surface for enhancing the interfacial properties of epoxy resin composites. Compos Sci Technol, 2018, 154: 28-36

[49] MartaDSA, TomaSH, ClantonJ, et al.. Decorated superparamagnetic iron oxide nanoparticles with monoclonal antibody and diethylene-triamine-pentaacetic acid labeled with thechnetium-99m and galium-68 for breast cancer imaging. Pharm Res, 2018, 35(1): 24

[50] VedakumariSW, SenthilR, SekarS, et al.. Enhancing anti-cancer activity of erlotinib by antibody conjugated nanofibrin-7n vitro studies on lung adenocarcinoma cell lines. Mater Chem Phys, 2019, 224: 328-333

[51] LeachJ, WangA, YeK, et al.. A RNA-DNA hybrid aptamer for nanoparticle-based prostate tumor targeted drug delivery. Int J Mol Sci, 2016, 17(3): 380

[52] WuH, ShiH, ZhangH, et al.. Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery. Biomaterials, 2014, 35(20): 5369-5380

[53] BichoA, PecaIN, RoqueA C, et al.. Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8. Int J Pharm, 2010, 399(1–2): 80-86

[54] DominguezAL, LustgartenJ. Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses. Vaccine, 2010, 28(5): 1383-1390

[55] WangCH, ChiouS H, ChouCP, et al.. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody. Nanomed Nanotechnol Biol Med, 2011, 7(1): 69-79

[56] SongH, HeR, WangK, et al.. Anti-HIF-1 alpha antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy. Biomaterials, 2010, 31(8): 2302-2312

[57] DingBY, WuX, FanW, et al.. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity. Int J Nanomed, 2011, 6: 1991-2005

[58] LangcharoenP, PunfaW, YodkeereeS, et al.. Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment. Arch Pharmacal Res, 2011, 34(10): 1679-1689

[59] ZhengXH, XingD, ZhouFF, et al.. Indocyanine green-containing canostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy. Mol Pharm, 2011, 8(2): 447-56

[60] BernardiRJ, LoweryAR, ThompsonPA, et al.. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol, 2008, 86(2): 165-172

[61] ChenS, FlorinasS, TeitgenA, et al.. Controlled Fab installation onto polymeric micelle nanoparticles for tuned bioactivity, 2017, 18(1): 666-80

[62] WilburDS, ChyanMA, HamlinDK, et al.. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-Labeled closo-decaborate(2-) conjugates of Fab’ as a means of decreasing kidney retention. Bioconjugate Chem, 2011, 22(6): 1089-1102

[63] HongLPT, ScobleJA, DoughtyL, et al.. Cancer-targeting antibody-drug conjugates: Site-specific conjugation of doxorubicin to anti-EGFR 528 Fab’ through a polyethylene glycol Linker. Aust J Chem, 2011, 64(6): 779-789

[64] GeogheganJC, FlemingR, DamschroderM, et al.. Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering. MAbs, 2016, 8(5): 941-950

[65] GeddieML, KohliN, KirpotinDB, et al.. Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting. MAbs, 2017, 9(1): 58-67

[66] Martínez-JotharL, BeztsinnaN, Van NostrumCF, et al.. Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical Internalization. Mol Pharmaceutics, 2019, 16(4): 1633-1647

[67] WillemsenRA, PecharM, CarlisleR, et al.. Multi-component polymeric system for tumour cell-specific gene delivery using a universal bungarotoxin linker. Pharm Res, 2010, 27(11): 2274-2282

[68] LuRM, ChangYL, ChenMS, et al.. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. Biomaterials, 2011, 32(12): 3265-3274

[69] HuCMJ, KaushalS, CaoHST, et al.. Half-Antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Mol Pharm, 2010, 7(3): 914-920

[70] HuangXH, PengXH, WangYQ, et al.. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. Acs Nano, 2010, 4(10): 5887-5896

[71] TalelliM, RijckenCJF, OliveiraS, et al.. Nanobody-Shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting. J Controlled Release, 2011, 151(2): 183-192

[72] SadeqzadehE, RahbarizadehF, AhmadvandD, et al.. Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells. J Controlled Release, 2011, 156(1): 85-91

[73] Van De BroekB, DevoogdtN, D’HollanderA, et al.. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. Acs Nano, 2011, 5(6): 4319-4328